331 related articles for article (PubMed ID: 31568636)
1. Platelet-rich plasma treatment for melasma: A pilot study.
Sirithanabadeekul P; Dannarongchai A; Suwanchinda A
J Cosmet Dermatol; 2020 Jun; 19(6):1321-1327. PubMed ID: 31568636
[TBL] [Abstract][Full Text] [Related]
2. Intradermal injection of tranexamic acid versus platelet-rich plasma in the treatment of melasma: a split-face comparative study.
Abd Elraouf IG; Obaid ZM; Fouda I
Arch Dermatol Res; 2023 Aug; 315(6):1763-1770. PubMed ID: 36856856
[TBL] [Abstract][Full Text] [Related]
3. Study of efficacy of microneedling and mesoneedling in the treatment of epidermal melasma: A pilot trial.
Farshi S; Mansouri P
J Cosmet Dermatol; 2020 May; 19(5):1093-1098. PubMed ID: 32196865
[TBL] [Abstract][Full Text] [Related]
4. Platelet-rich plasma is a useful therapeutic option in melasma.
Hofny ERM; Abdel-Motaleb AA; Ghazally A; Ahmed AM; Hussein MRA
J Dermatolog Treat; 2019 Jun; 30(4):396-401. PubMed ID: 30220226
[No Abstract] [Full Text] [Related]
5. A comparative evaluation of the efficacy of intralesional tranexamic acid versus platelet rich plasma in the treatment of melasma.
Patil NK; Bubna AK
Dermatol Ther; 2022 Jul; 35(7):e15534. PubMed ID: 35460158
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of platelet-rich plasma efficacy in melasma.
Acar A; Ozturk A; Sokmen N; Unal I; Ertam Sagduyu I
J Cosmet Laser Ther; 2022 Jul; 24(1-5):36-39. PubMed ID: 35852165
[TBL] [Abstract][Full Text] [Related]
7. Study of autologous platelet-rich-plasma versus its combination with intense pulsed light in treatment of melasma.
Adel S; Serri A; Abd El-Raheem T
Dermatol Ther; 2021 Jul; 34(4):e15008. PubMed ID: 34041826
[TBL] [Abstract][Full Text] [Related]
8. Tranexamic Acid for Melasma Treatment: A Split-Face Study.
Ebrahim HM; Said Abdelshafy A; Khattab F; Gharib K
Dermatol Surg; 2020 Nov; 46(11):e102-e107. PubMed ID: 32701529
[TBL] [Abstract][Full Text] [Related]
9. Platelet-Rich Plasma in Melasma-A Systematic Review.
Sarkar R; Gupta M
Dermatol Surg; 2022 Jan; 48(1):131-134. PubMed ID: 34904579
[TBL] [Abstract][Full Text] [Related]
10. Autologous intralesional platelet rich plasma improves melasma.
Tuknayat A; Thami GP; Bhalla M; Sandhu JK
Dermatol Ther; 2021 Mar; 34(2):e14881. PubMed ID: 33591615
[TBL] [Abstract][Full Text] [Related]
11. Intradermal Platelet-Rich Plasma for the Treatment of Melasma: A Clinical and Dermoscopic Evaluation in Dark Skin.
Rout A; Mani S; Bala N
J Cutan Aesthet Surg; 2023; 16(4):300-305. PubMed ID: 38314355
[TBL] [Abstract][Full Text] [Related]
12. Treatment of atrophic acne scars using autologous platelet-rich plasma vs combined subcision and autologous platelet-rich plasma: A split-face comparative study.
Hassan AS; El-Hawary MS; Abdel Raheem HM; Abdallah SH; El-Komy MM
J Cosmet Dermatol; 2020 Feb; 19(2):456-461. PubMed ID: 31241854
[TBL] [Abstract][Full Text] [Related]
13. Combination of autologous platelet rich plasma and hydroquinone 4% is more effective than hydroquinone alone in treatment of melasma: A split-face comparative study.
Tekam PS; Belgaumkar VA
Dermatol Ther; 2022 Nov; 35(11):e15761. PubMed ID: 36068674
[TBL] [Abstract][Full Text] [Related]
14. Role of Platelet-Rich Plasma Therapy as an Adjuvant in Treatment of Melasma.
Bikash C; Sarkar R; Relhan V; Singh S
Dermatol Surg; 2022 Apr; 48(4):429-434. PubMed ID: 35143442
[TBL] [Abstract][Full Text] [Related]
15. Effects of a fractional picosecond 1,064 nm laser for the treatment of dermal and mixed type melasma.
Chalermchai T; Rummaneethorn P
J Cosmet Laser Ther; 2018 Jun; 20(3):134-139. PubMed ID: 29020467
[TBL] [Abstract][Full Text] [Related]
16. Exploring the potential of intradermal platelet-rich plasma in treating acquired bilateral nevus of Ota-like macule (Hori's nevus): A pilot study.
Deeudomwongsa P; Chumsaengsri C; Aristizabal M; Kiatsurayanon C
J Cosmet Dermatol; 2024 Mar; 23(3):803-811. PubMed ID: 38088245
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of TGF-β protein in the lesional skins of melasma patients following treatment with platelet-rich plasma.
Hofny ERM; Hussein MRA; Ghazally A; Ahmed AM; Abdel-Motaleb AA
J Cosmet Laser Ther; 2019; 21(7-8):382-389. PubMed ID: 31554441
[No Abstract] [Full Text] [Related]
18. A randomized, observer-blinded, comparison of combined 1064-nm Q-switched neodymium-doped yttrium-aluminium-garnet laser plus 30% glycolic acid peel vs. laser monotherapy to treat melasma.
Park KY; Kim DH; Kim HK; Li K; Seo SJ; Hong CK
Clin Exp Dermatol; 2011 Dec; 36(8):864-70. PubMed ID: 21973194
[TBL] [Abstract][Full Text] [Related]
19. Comparing the Efficacy of Patelet-rich Plasma (PRP) versus Tranexamic Acid (4mg/mL) as Intradermal Treatments of Melasma.
Mumtaz M; Chandio TH; Shahzad MK; Hanif N; Anwar S; Rafique S
J Coll Physicians Surg Pak; 2021 May; 31(5):502-505. PubMed ID: 34027858
[TBL] [Abstract][Full Text] [Related]
20. Platelet-rich plasma injections in the treatment of male androgenetic alopecia: A randomized placebo-controlled crossover study.
Dicle Ö; Bilgic Temel A; Gülkesen KH
J Cosmet Dermatol; 2020 May; 19(5):1071-1077. PubMed ID: 31532574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
